Polygenic hazard score is associated with prostate cancer in multi-ethnic populations

Mostra el registre complet Registre parcial de l'ítem

• dc.contributor.author Huynh-Le, Minh Phuong
• dc.contributor.author Kogevinas, Manolis
• dc.contributor.author PRACTICAL Consortium
• dc.date.accessioned 2021-07-05T06:58:03Z
• dc.date.available 2021-07-05T06:58:03Z
• dc.date.issued 2021
• dc.description.abstract Genetic models for cancer have been evaluated using almost exclusively European data, which could exacerbate health disparities. A polygenic hazard score (PHS1) is associated with age at prostate cancer diagnosis and improves screening accuracy in Europeans. Here, we evaluate performance of PHS2 (PHS1, adapted for OncoArray) in a multi-ethnic dataset of 80,491 men (49,916 cases, 30,575 controls). PHS2 is associated with age at diagnosis of any and aggressive (Gleason score ≥ 7, stage T3-T4, PSA ≥ 10 ng/mL, or nodal/distant metastasis) cancer and prostate-cancer-specific death. Associations with cancer are significant within European (n = 71,856), Asian (n = 2,382), and African (n = 6,253) genetic ancestries (p < 10-180). Comparing the 80th/20th PHS2 percentiles, hazard ratios for prostate cancer, aggressive cancer, and prostate-cancer-specific death are 5.32, 5.88, and 5.68, respectively. Within European, Asian, and African ancestries, hazard ratios for prostate cancer are: 5.54, 4.49, and 2.54, respectively. PHS2 risk-stratifies men for any, aggressive, and fatal prostate cancer in a multi-ethnic dataset.
• dc.format.mimetype application/pdf
• dc.identifier.citation Huynh-Le MP, Fan CC, Karunamuni R, Thompson WK, Martinez ME, Eeles RA et al. Polygenic hazard score is associated with prostate cancer in multi-ethnic populations. Nat Commun. 2021;12(1):1236. DOI: 10.1038/s41467-021-21287-0
• dc.identifier.doi http://dx.doi.org/10.1038/s41467-021-21287-0
• dc.identifier.uri http://hdl.handle.net/10230/48073
• dc.language.iso eng
• dc.publisher Nature Research
• dc.relation.ispartof Nat Commun. 2021;12(1):1236
• dc.rights © The Author(s) 2021. Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
• dc.rights.accessRights info:eu-repo/semantics/openAccess
• dc.rights.uri http://creativecommons.org/licenses/by/4.0/
• dc.subject.keyword Biomarkers
• dc.subject.keyword Medical research
• dc.subject.keyword Oncology
• dc.title Polygenic hazard score is associated with prostate cancer in multi-ethnic populations
• dc.type info:eu-repo/semantics/article
• dc.type.version info:eu-repo/semantics/publishedVersion